Contralateral parenchymal enhancement on dynamic contrast-enhanced MRI reproduces as a biomarker of survival in ER-positive/HER2-negative breast cancer patients-Reference-Cited by-同舟云学术

Contralateral parenchymal enhancement on dynamic contrast-enhanced MRI reproduces as a biomarker of survival in ER-positive/HER2-negative breast cancer patients

Published:2018-05-07 Issue:11 Volume:28 Page:4705-4716
ISSN:0938-7994
Container-title:European Radiology
language:en
Short-container-title:Eur Radiol

Author:

van der Velden Bas H. M.,Sutton Elizabeth J.,Carbonaro Luca A.,Pijnappel Ruud M.,Morris Elizabeth A.,Gilhuijs Kenneth G. A.

Funder

Stichting voor de Technische Wetenschappen

National Cancer Institute

René Vogels Stichting

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/article/10.1007/s00330-018-5470-7/fulltext.html

Reference38 articles.

1. De Ronde JJ, Hannemann J, Halfwerk H et al (2010) Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response. Breast Cancer Res Treat 119:119–126

2. Galea MH, Blamey RW, Ellis IO, Elston CE (1992) The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat 22:207–219

3. Wishart GC, Azzato EM, Greenberg DC et al (2010) PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer. Breast Cancer Res 12:R1

4. Ravdin PM, Siminoff LA, Davis GJ et al (2001) Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol 19:980–991

5. van’t Veer LJ, Dai H, van de Vijver MJ et al (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530–536

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term Survival in Breast Cancer Patients Is Associated with Contralateral Parenchymal Enhancement at MRI: Outcomes of the SELECT Study;Radiology;2023-05-01

2. Post-Processing Bias Field Inhomogeneity Correction for Assessing Background Parenchymal Enhancement on Breast MRI as a Quantitative Marker of Treatment Response;Tomography;2022-03-22

3. Background parenchymal enhancement and uptake as breast cancer imaging biomarkers: A state-of-the-art review;Clinical Imaging;2022-03

4. Leveraging Clinical Characteristics for Improved Deep Learning-Based Kidney Tumor Segmentation on CT;Lecture Notes in Computer Science;2022

5. Contralateral parenchymal enhancement on MRI is associated with tumor proteasome pathway gene expression and overall survival of early ER+/HER2-breast cancer patients;The Breast;2021-12